Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02997475 · ClinicalTrials.gov registry record

Neural Bases of Multiple Forms of Self-regulatory Control in Bulimia Nervosa

A clinical trial of Bulimia Nervosa, sponsored by University of California, San Diego.

Completed
Registry status
89
Enrollment target
1
Study location

NCT02997475: Completed study of Bulimia Nervosa, sponsored by University of California, San Diego.

NCT02997475 is a study of Bulimia Nervosa that has completed, run by University of California, San Diego. The registered enrollment target is 89 participants, below the 1,734-participant average among 23 other Bulimia Nervosa trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02997475, a study of Bulimia Nervosa, has completed, sponsored by University of California, San Diego.

COMPLETED
Registry status
89 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to investigate areas of the brain responsible for self-regulation in adult women who have never had an eating disorder with women who have bulimia nervosa. More specifically, investigators are interested in changes in brain activation (e.g., changes in blood flow and oxygen use) when inhibiting responses and regulating emotions. Data collection will rely on a technology called functional magnetic resonance imaging (fMRI).

Primary Outcome

Functional Magnetic Resonance Imaging will be used to assess brain activation associated with motor inhibitory control and affect regulation in women with bulimia nervosa (BN)

Conditions Studied

Study Locations (1)

California

  • UCSD Eating Disorders Center for Treatment and Research - San Diego

Trial Details

FieldValue
Enrollment Target 89 participants
Start Date 2016-06
Est. Completion 2022-07-31
University of California, San Diego

775 total trials

What the finished NCT02997475 record still lists

NCT02997475 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 89 participants, a relatively small participant target, below the 1,734-participant average among 23 other Bulimia Nervosa trials with a reported enrollment target (95% lower).

The record links to 1 condition, with Bulimia Nervosa appearing as the primary indexed condition, and to 0 interventions.

NCT02997475 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT02997475 about?

NCT02997475 is a clinical study titled "Neural Bases of Multiple Forms of Self-regulatory Control in Bulimia Nervosa". The purpose of this study is to investigate areas of the brain responsible for self-regulation in adult women who have never had an eating disorder with women who have bulimia nervosa. More specifically, investigators are interested in changes in brain activation (e.g., changes in blood flow and oxy...

What is the current status of trial NCT02997475?

This trial is currently completed. The enrollment target is 89 participants. The study started on 2016-06. Estimated completion is 2022-07-31.

What conditions does trial NCT02997475 study?

This clinical trial studies the following conditions: Bulimia Nervosa.

Who is sponsoring clinical trial NCT02997475?

This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02997475 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Bulimia Nervosa

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02997475's enrollment target sits among peer trials

89 9th of 23 higher than 15 of 23 other Bulimia Nervosa trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Bulimia Nervosa trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03682289 · 89 participants · Phase 2

    Ceralasertib (AZD6738) Alone and in Combination With Olaparib or Durvalumab in Patients With Solid Tumors

  • NCT04787939 · 89 participants · NA

    Early Feeding After Oral Cavity Reconstruction

  • NCT05480449 · 89 participants · Phase 1

    Autologous HuCART19 T Cells Manufactured Using the CliniMACS Prodigy Platform for Pediatric B-ALL (huCART19 Prodigy)

  • NCT05604131 · 89 participants · Phase 2

    Cardiac MRI-guided Deferiprone Therapy for Acute Myocardial Infarction Patients

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02997475, the US trial registry maintained by the National Library of Medicine. NCT02997475 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.